. (a) Scheme of PAIGE for detecting kinase activity. AD is fused to a kinase substrate peptide and SH2 is fused to DB. Both fusion proteins, AD-peptide and SH2-DB, are constitutively expressed under T7 promoters from input DNA templates (step 1). Phosphorylation of the substrate peptide by a kinase (step 2) results in the peptide's binding to SH2-DB which is bound to the upstream-activation sequence (UAS) on the reporter DNA (step 3). AD activates the promoter-bound RNA polymerase (RNAP) (step 4) to express the reporter gene, which produces GFP (step 5). (b) Detection of Abl kinase activity in a microwell plate using PAIGE. The GFP fluorescence is monitored during incubation at 37°C in a microplate reader. (c) Titration curve of pure Abl kinase using drop-based PAIGE. The fluorescence of drops with Abl kinase is normalized by that of drops without Abl kinase. The normalized activated fluorescence, F, is obtained by subtracting one. After 36 hours, the apoptotic fraction drops dramatically because in this time interval the the imatinib-sensitive cells become necrotic and are removed by centrifugation during the sample preparation process. Supplementary Fig. 6 . Work flow of the experimental steps for monitoring the kinase activity, apoptosis and necrosis of single K562 cells during imatinib treatment. 
